1Larson-Meyer, DE, Newcomer, BR, Heilbronn, LK, et al. (2008) Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity (Silver Spring) 16, 1355–1362.
2Sanyal, AJ, Chalasani, N, Kowdley, KV, et al. (2010) Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med 362, 1675–1685.
3de Luis, DA, Aller, R, Izaola, O, et al. (2010) Effect of two different hypocaloric diets in transaminases and insulin resistance in nonalcoholic fatty liver disease and obese patients. Nutr Hosp 25, 730–735.
4Musso, G, Gambino, R, Cassader, M, et al. (2010) A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease. Hepatology 52, 79–104.
5Malaguarnera, M, Gargante, MP, Russo, C, et al. (2010) l-Carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis – a randomized and controlled clinical trial. Am J Gastroenterol 105, 1338–1345.
6Zein, CO, Yerian, LM, Gogate, P, et al. (2011) Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial. Hepatology 54, 1610–1619.
7Vitaglione, P, Morisco, F, Mazzone, G, et al. (2010) Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins. Hepatology 52, 1652–1661.
8Chalasani, N, Younossi, Z, Lavine, JE, et al. (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55, 2005–2023.
9Matsuda, H, Murakami, T, Kageura, T, et al. (1998) Hepatoprotective and nitric oxide production inhibitory activities of coumarin and polyacetylene constituents from the roots of Angelica furcijuga. Bioorg Med Chem Lett 8, 2191–2196.
10Rajarajeswari, N & Pari, L (2011) Antioxidant role of coumarin on streptozotocin-nicotinamide-induced type 2 diabetic rats. J Biochem Mol Toxicol 25, 355–361.
11Um, MY, Moon, MK, Ahn, J, et al. (2013) Coumarin attenuates hepatic steatosis by downregulating lipogenic gene expression in mice fed a high-fat diet. Br J Nutr 109, 1590–1597.
12Mielke, H, Abraham, K, Gotz, M, et al. (2011) Physiologically based toxicokinetic modelling as a tool to assess target organ toxicity in route-to-route extrapolation – the case of coumarin. Toxicol Lett 202, 100–110.
13Felter, SP, Vassallo, JD, Carlton, BD, et al. (2006) A safety assessment of coumarin taking into account species-specificity of toxicokinetics. Food Chem Toxicol 44, 462–475.